Information regarding Azstarys availability in Australia is currently limited. The drug has received approval in the United States for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients aged six years and older [1].
When might Azstarys be available in Australia?
There is no publicly announced timeline for when Azstarys may become available in Australia. Regulatory approval processes in Australia, managed by the Therapeutic Goods Administration (TGA), can take time and depend on applications submitted by the manufacturer.
What is Azstarys used for?
Azstarys is a central nervous system stimulant prescribed for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) [1]. It is intended for use as part of a comprehensive treatment program that may include psychological, educational, and social interventions.
How does Azstarys work?
Azstarys is a combination medication containing the prodrug serdexymethylphenidate and dexmethylphenidate. Serdexmethylphenidate is converted to dexmethylphenidate in the body, and dexmethylphenidate itself is also released. Dexmethylphenidate is believed to affect neurotransmitters in the brain, specifically norepinephrine and dopamine, which are thought to play a role in managing ADHD symptoms [1].
What are the active ingredients in Azstarys?
The active ingredients in Azstarys are serdexmethylphenidate and dexmethylphenidate [1].
Who manufactures Azstarys?
Azstarys is manufactured by Corium Inc., a company specializing in the development and commercialization of specialty pharmaceutical products [1].
What is the difference between Azstarys and other ADHD medications?
Azstarys is a prodrug formulation, meaning one of its active components is converted into the active drug within the body. This formulation is designed to provide a sustained release of dexmethylphenidate throughout the day. Other ADHD medications may use different stimulant compounds or release mechanisms. For example, some medications release methylphenidate, while others may contain amphetamine-based stimulants. The specific formulation and active ingredients can influence how the medication is absorbed, metabolized, and its duration of effect.
Are there any potential side effects of Azstarys?
Common side effects reported for Azstarys in clinical trials include decreased appetite, insomnia, weight loss, dry mouth, and anxiety [1]. Serious side effects can include psychiatric problems, cardiovascular issues, and circulation problems in the fingers and toes. It is important to discuss potential risks and benefits with a healthcare professional.
What is the patent status of Azstarys?
Information on Azstarys's patent status and any associated exclusivity periods can be tracked through resources like DrugPatentWatch.com [2]. Patents protect the intellectual property of the drug, influencing market exclusivity and the potential for generic or biosimilar competition.
[1] https://www.azstarys.com/
[2] https://drugpatentwatch.com/